• World
Where the impacts of the investment may be experienced.
Financial Institutions
  • Netherlands Development Finance Company (FMO)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Bank Risk Rating
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Jul 24, 2020
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
Delft Imaging Systems BV
The holder of the loan, grant, or other investment.
  • Industry and Trade
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
The categories of the bank investment: loan, grant, etc.
Investment Amount (USD)
Not Disclosed
When disclosed, the bank did not provide this value. Please review updated project documents for more information.
Primary Source

Original disclosure @ FMO website

Updated in EWS Dec 1, 2020

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description

Delft Imaging Systems BV is specialised in medical solutions to help screen for the lung disease tuberculosis which still kills 1.6 million people every year. Its portfolio of solutions includes a range of X-ray systems, mobile clinics and artificial intelligence software. In 2016, Delft Imaging opened a branch office in Accra, Ghana and in 2018 in Johannesburg, South Africa. To date, Delft Imaging is active in over 40 different countries and has screened more than 6 million people for tuberculosis.

This funding will support Delft Imaging to implement a cloud-based artificial intelligence tool for the detection of COVID-19 cases, CAD4COVID. The CAD4COVID module analyses a standard chest X-ray image and has been developed with the intention to support the triage of potential COVID-19 cases in resource-constrained settings.


Investment Description
  • Netherlands Development Finance Company (FMO)
Private Actors
Contact Information

Project contacts not available at the time of disclosure.



As part of FMO's ex-ante disclosure (disclosure of transactions before contracting), you can send requests or questions for additional information to:


Communities who believe they will be negatively affected by a project funded by the Dutch Development Bank (FMO) may be able to file a complaint with the Independent Complaints Mechanism, which is the joint independent accountability mechanism of the Dutch Development Bank (FMO) and the German Investment Corporation (KfW). A complaint can be filed in writing, by email, post, or online. The complaint can be filed in English or any other language of the complainant. The Independent Complaints Mechanism is comprised of a three-member Independent Expert Panel and it can provide either problem-solving, compliance review or both, in either order. Additional information about this accountability mechanism, including a guide and template for filing a complaint, can be found at: